nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Levothyroxine—hypothyroidism	0.133	0.206	CbGbCtD
Clomipramine—ALB—Liothyronine—hypothyroidism	0.133	0.206	CbGbCtD
Clomipramine—ALB—Liotrix—hypothyroidism	0.129	0.201	CbGbCtD
Clomipramine—ABCB1—Levothyroxine—hypothyroidism	0.0694	0.108	CbGbCtD
Clomipramine—ABCB1—Liothyronine—hypothyroidism	0.0694	0.108	CbGbCtD
Clomipramine—ABCB1—Liotrix—hypothyroidism	0.0677	0.105	CbGbCtD
Clomipramine—CYP3A4—Levothyroxine—hypothyroidism	0.0416	0.0647	CbGbCtD
Clomipramine—GSTP1—urine—hypothyroidism	0.00677	0.0682	CbGeAlD
Clomipramine—Pharyngeal oedema—Liotrix—hypothyroidism	0.00628	0.0277	CcSEcCtD
Clomipramine—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00617	0.0273	CcSEcCtD
Clomipramine—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00617	0.0273	CcSEcCtD
Clomipramine—HTR2A—cerebellar cortex—hypothyroidism	0.00561	0.0566	CbGeAlD
Clomipramine—Muscle twitching—Liothyronine—hypothyroidism	0.00506	0.0223	CcSEcCtD
Clomipramine—CYP2C19—urine—hypothyroidism	0.00467	0.0471	CbGeAlD
Clomipramine—Hyperthyroidism—Liotrix—hypothyroidism	0.00454	0.0201	CcSEcCtD
Clomipramine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00398	0.0176	CcSEcCtD
Clomipramine—CYP1A2—urine—hypothyroidism	0.00381	0.0384	CbGeAlD
Clomipramine—SLC6A2—nerve—hypothyroidism	0.00342	0.0345	CbGeAlD
Clomipramine—HTR2A—urine—hypothyroidism	0.00298	0.03	CbGeAlD
Clomipramine—CYP3A4—urine—hypothyroidism	0.00276	0.0278	CbGeAlD
Clomipramine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00274	0.0121	CcSEcCtD
Clomipramine—Myocardial infarction—Liothyronine—hypothyroidism	0.00273	0.012	CcSEcCtD
Clomipramine—CYP2D6—urine—hypothyroidism	0.00272	0.0274	CbGeAlD
Clomipramine—Intestinal obstruction—Liotrix—hypothyroidism	0.00263	0.0116	CcSEcCtD
Clomipramine—Cyanosis—Liotrix—hypothyroidism	0.00254	0.0112	CcSEcCtD
Clomipramine—HRH2—heart—hypothyroidism	0.00241	0.0243	CbGeAlD
Clomipramine—HRH2—cardiovascular system—hypothyroidism	0.00227	0.0229	CbGeAlD
Clomipramine—Coma—Dextrothyroxine—hypothyroidism	0.00223	0.00985	CcSEcCtD
Clomipramine—Coma—Levothyroxine—hypothyroidism	0.00223	0.00985	CcSEcCtD
Clomipramine—Arrhythmia—Liothyronine—hypothyroidism	0.00223	0.00984	CcSEcCtD
Clomipramine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00213	0.0094	CcSEcCtD
Clomipramine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00213	0.0094	CcSEcCtD
Clomipramine—HTR2A—nerve—hypothyroidism	0.00206	0.0207	CbGeAlD
Clomipramine—Disorientation—Dextrothyroxine—hypothyroidism	0.00198	0.00874	CcSEcCtD
Clomipramine—Disorientation—Levothyroxine—hypothyroidism	0.00198	0.00874	CcSEcCtD
Clomipramine—Cellulitis—Liotrix—hypothyroidism	0.00197	0.00872	CcSEcCtD
Clomipramine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00195	0.00863	CcSEcCtD
Clomipramine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00195	0.00863	CcSEcCtD
Clomipramine—Oliguria—Liotrix—hypothyroidism	0.00195	0.0086	CcSEcCtD
Clomipramine—Increased appetite—Dextrothyroxine—hypothyroidism	0.00189	0.00833	CcSEcCtD
Clomipramine—Increased appetite—Levothyroxine—hypothyroidism	0.00189	0.00833	CcSEcCtD
Clomipramine—Hypertension—Liothyronine—hypothyroidism	0.00188	0.00828	CcSEcCtD
Clomipramine—Muscle twitching—Liotrix—hypothyroidism	0.00183	0.00807	CcSEcCtD
Clomipramine—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00182	0.00802	CcSEcCtD
Clomipramine—Cardiac failure—Levothyroxine—hypothyroidism	0.00182	0.00802	CcSEcCtD
Clomipramine—HRH2—adrenal gland—hypothyroidism	0.0018	0.0181	CbGeAlD
Clomipramine—HRH2—blood—hypothyroidism	0.0018	0.0181	CbGeAlD
Clomipramine—GSTP1—adrenal cortex—hypothyroidism	0.00179	0.0181	CbGeAlD
Clomipramine—Affect lability—Dextrothyroxine—hypothyroidism	0.00174	0.0077	CcSEcCtD
Clomipramine—Affect lability—Levothyroxine—hypothyroidism	0.00174	0.0077	CcSEcCtD
Clomipramine—GSTP1—heart—hypothyroidism	0.00173	0.0175	CbGeAlD
Clomipramine—Tachycardia—Liothyronine—hypothyroidism	0.00173	0.00764	CcSEcCtD
Clomipramine—Irritability—Dextrothyroxine—hypothyroidism	0.00169	0.00747	CcSEcCtD
Clomipramine—Irritability—Levothyroxine—hypothyroidism	0.00169	0.00747	CcSEcCtD
Clomipramine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00168	0.00744	CcSEcCtD
Clomipramine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00168	0.00744	CcSEcCtD
Clomipramine—Mood swings—Dextrothyroxine—hypothyroidism	0.00168	0.00741	CcSEcCtD
Clomipramine—Mood swings—Levothyroxine—hypothyroidism	0.00168	0.00741	CcSEcCtD
Clomipramine—Hypotension—Liothyronine—hypothyroidism	0.00166	0.00732	CcSEcCtD
Clomipramine—Dehydration—Dextrothyroxine—hypothyroidism	0.00165	0.00727	CcSEcCtD
Clomipramine—Dehydration—Levothyroxine—hypothyroidism	0.00165	0.00727	CcSEcCtD
Clomipramine—Coma—Liotrix—hypothyroidism	0.00164	0.00724	CcSEcCtD
Clomipramine—GSTP1—cardiovascular system—hypothyroidism	0.00164	0.0165	CbGeAlD
Clomipramine—Hyperkinesia—Liotrix—hypothyroidism	0.00157	0.00691	CcSEcCtD
Clomipramine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00156	0.0069	CcSEcCtD
Clomipramine—Muscular weakness—Levothyroxine—hypothyroidism	0.00156	0.0069	CcSEcCtD
Clomipramine—Dysphagia—Levothyroxine—hypothyroidism	0.00153	0.00676	CcSEcCtD
Clomipramine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00153	0.00676	CcSEcCtD
Clomipramine—Sweating increased—Dextrothyroxine—hypothyroidism	0.00149	0.00659	CcSEcCtD
Clomipramine—Sweating increased—Levothyroxine—hypothyroidism	0.00149	0.00659	CcSEcCtD
Clomipramine—ALB—heart—hypothyroidism	0.00149	0.015	CbGeAlD
Clomipramine—GSTP1—gonad—hypothyroidism	0.00149	0.015	CbGeAlD
Clomipramine—HTR2B—adrenal cortex—hypothyroidism	0.00148	0.0149	CbGeAlD
Clomipramine—Disorientation—Liotrix—hypothyroidism	0.00146	0.00643	CcSEcCtD
Clomipramine—GSTP1—pituitary gland—hypothyroidism	0.00145	0.0146	CbGeAlD
Clomipramine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00144	0.00634	CcSEcCtD
Clomipramine—HTR2B—heart—hypothyroidism	0.00143	0.0144	CbGeAlD
Clomipramine—HRH2—liver—hypothyroidism	0.00141	0.0142	CbGeAlD
Clomipramine—Body temperature increased—Liothyronine—hypothyroidism	0.0014	0.00619	CcSEcCtD
Clomipramine—Increased appetite—Liotrix—hypothyroidism	0.00139	0.00612	CcSEcCtD
Clomipramine—Weight decreased—Levothyroxine—hypothyroidism	0.00139	0.00612	CcSEcCtD
Clomipramine—Weight decreased—Dextrothyroxine—hypothyroidism	0.00139	0.00612	CcSEcCtD
Clomipramine—HTR2B—cardiovascular system—hypothyroidism	0.00135	0.0136	CbGeAlD
Clomipramine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00135	0.00594	CcSEcCtD
Clomipramine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00135	0.00594	CcSEcCtD
Clomipramine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00134	0.00591	CcSEcCtD
Clomipramine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00134	0.00591	CcSEcCtD
Clomipramine—Cardiac failure—Liotrix—hypothyroidism	0.00134	0.0059	CcSEcCtD
Clomipramine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00133	0.00587	CcSEcCtD
Clomipramine—Sweating—Levothyroxine—hypothyroidism	0.00131	0.00578	CcSEcCtD
Clomipramine—Sweating—Dextrothyroxine—hypothyroidism	0.00131	0.00578	CcSEcCtD
Clomipramine—GSTP1—adrenal gland—hypothyroidism	0.00129	0.013	CbGeAlD
Clomipramine—GSTP1—blood—hypothyroidism	0.00129	0.013	CbGeAlD
Clomipramine—Affect lability—Liotrix—hypothyroidism	0.00128	0.00566	CcSEcCtD
Clomipramine—GSTP1—thyroid gland—hypothyroidism	0.00125	0.0126	CbGeAlD
Clomipramine—Irritability—Liotrix—hypothyroidism	0.00124	0.00549	CcSEcCtD
Clomipramine—Cardiac arrest—Liotrix—hypothyroidism	0.00124	0.00547	CcSEcCtD
Clomipramine—Mood swings—Liotrix—hypothyroidism	0.00123	0.00545	CcSEcCtD
Clomipramine—Dehydration—Liotrix—hypothyroidism	0.00121	0.00535	CcSEcCtD
Clomipramine—GSTP1—female gonad—hypothyroidism	0.00121	0.0122	CbGeAlD
Clomipramine—Hypokalaemia—Liotrix—hypothyroidism	0.00119	0.00524	CcSEcCtD
Clomipramine—Muscular weakness—Liotrix—hypothyroidism	0.00115	0.00507	CcSEcCtD
Clomipramine—Flushing—Dextrothyroxine—hypothyroidism	0.00114	0.00502	CcSEcCtD
Clomipramine—Flushing—Levothyroxine—hypothyroidism	0.00114	0.00502	CcSEcCtD
Clomipramine—Dysphagia—Liotrix—hypothyroidism	0.00113	0.00497	CcSEcCtD
Clomipramine—ALB—adrenal gland—hypothyroidism	0.00111	0.0112	CbGeAlD
Clomipramine—Bronchospasm—Liotrix—hypothyroidism	0.00111	0.00489	CcSEcCtD
Clomipramine—Sweating increased—Liotrix—hypothyroidism	0.0011	0.00484	CcSEcCtD
Clomipramine—Arrhythmia—Levothyroxine—hypothyroidism	0.00109	0.00483	CcSEcCtD
Clomipramine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00109	0.00483	CcSEcCtD
Clomipramine—SLC6A2—gonad—hypothyroidism	0.00109	0.011	CbGeAlD
Clomipramine—Bronchitis—Liotrix—hypothyroidism	0.00108	0.00478	CcSEcCtD
Clomipramine—Alopecia—Dextrothyroxine—hypothyroidism	0.00108	0.00478	CcSEcCtD
Clomipramine—Alopecia—Levothyroxine—hypothyroidism	0.00108	0.00478	CcSEcCtD
Clomipramine—SLC6A4—blood—hypothyroidism	0.00108	0.0109	CbGeAlD
Clomipramine—GSTP1—testis—hypothyroidism	0.00107	0.0108	CbGeAlD
Clomipramine—HTR2B—adrenal gland—hypothyroidism	0.00107	0.0108	CbGeAlD
Clomipramine—HTR2B—blood—hypothyroidism	0.00107	0.0108	CbGeAlD
Clomipramine—Tension—Dextrothyroxine—hypothyroidism	0.00105	0.00462	CcSEcCtD
Clomipramine—Tension—Levothyroxine—hypothyroidism	0.00105	0.00462	CcSEcCtD
Clomipramine—Nervousness—Levothyroxine—hypothyroidism	0.00104	0.00458	CcSEcCtD
Clomipramine—Nervousness—Dextrothyroxine—hypothyroidism	0.00104	0.00458	CcSEcCtD
Clomipramine—HTR2B—thyroid gland—hypothyroidism	0.00103	0.0104	CbGeAlD
Clomipramine—Weight decreased—Liotrix—hypothyroidism	0.00102	0.0045	CcSEcCtD
Clomipramine—GSTP1—liver—hypothyroidism	0.00101	0.0102	CbGeAlD
Clomipramine—Tremor—Levothyroxine—hypothyroidism	0.001	0.00441	CcSEcCtD
Clomipramine—Tremor—Dextrothyroxine—hypothyroidism	0.001	0.00441	CcSEcCtD
Clomipramine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00099	0.00437	CcSEcCtD
Clomipramine—GSTP1—cerebellum—hypothyroidism	0.000989	0.00997	CbGeAlD
Clomipramine—Myocardial infarction—Liotrix—hypothyroidism	0.000984	0.00435	CcSEcCtD
Clomipramine—Agitation—Dextrothyroxine—hypothyroidism	0.00098	0.00433	CcSEcCtD
Clomipramine—Agitation—Levothyroxine—hypothyroidism	0.00098	0.00433	CcSEcCtD
Clomipramine—Sweating—Liotrix—hypothyroidism	0.000963	0.00425	CcSEcCtD
Clomipramine—SLC6A2—adrenal gland—hypothyroidism	0.000949	0.00956	CbGeAlD
Clomipramine—Palpitations—Levothyroxine—hypothyroidism	0.000943	0.00416	CcSEcCtD
Clomipramine—Palpitations—Dextrothyroxine—hypothyroidism	0.000943	0.00416	CcSEcCtD
Clomipramine—Convulsion—Dextrothyroxine—hypothyroidism	0.000924	0.00408	CcSEcCtD
Clomipramine—Convulsion—Levothyroxine—hypothyroidism	0.000924	0.00408	CcSEcCtD
Clomipramine—ALB—testis—hypothyroidism	0.000917	0.00924	CbGeAlD
Clomipramine—Arthralgia—Dextrothyroxine—hypothyroidism	0.000908	0.00401	CcSEcCtD
Clomipramine—Arthralgia—Levothyroxine—hypothyroidism	0.000908	0.00401	CcSEcCtD
Clomipramine—Anxiety—Dextrothyroxine—hypothyroidism	0.000905	0.004	CcSEcCtD
Clomipramine—Anxiety—Levothyroxine—hypothyroidism	0.000905	0.004	CcSEcCtD
Clomipramine—ADRA2A—heart—hypothyroidism	0.000898	0.00905	CbGeAlD
Clomipramine—Hypoaesthesia—Liotrix—hypothyroidism	0.000897	0.00396	CcSEcCtD
Clomipramine—CYP2C19—blood—hypothyroidism	0.000893	0.009	CbGeAlD
Clomipramine—Confusional state—Dextrothyroxine—hypothyroidism	0.000878	0.00388	CcSEcCtD
Clomipramine—Confusional state—Levothyroxine—hypothyroidism	0.000878	0.00388	CcSEcCtD
Clomipramine—ALB—liver—hypothyroidism	0.000867	0.00874	CbGeAlD
Clomipramine—Shock—Levothyroxine—hypothyroidism	0.000857	0.00378	CcSEcCtD
Clomipramine—Shock—Dextrothyroxine—hypothyroidism	0.000857	0.00378	CcSEcCtD
Clomipramine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00085	0.00375	CcSEcCtD
Clomipramine—Tachycardia—Levothyroxine—hypothyroidism	0.00085	0.00375	CcSEcCtD
Clomipramine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000842	0.00372	CcSEcCtD
Clomipramine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000842	0.00372	CcSEcCtD
Clomipramine—Flushing—Liotrix—hypothyroidism	0.000837	0.00369	CcSEcCtD
Clomipramine—Arrhythmia—Liotrix—hypothyroidism	0.000805	0.00356	CcSEcCtD
Clomipramine—Alopecia—Liotrix—hypothyroidism	0.000797	0.00352	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000793	0.0035	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000793	0.0035	CcSEcCtD
Clomipramine—Insomnia—Levothyroxine—hypothyroidism	0.000788	0.00348	CcSEcCtD
Clomipramine—Insomnia—Dextrothyroxine—hypothyroidism	0.000788	0.00348	CcSEcCtD
Clomipramine—SLC6A2—testis—hypothyroidism	0.000785	0.00791	CbGeAlD
Clomipramine—Dyspnoea—Levothyroxine—hypothyroidism	0.000776	0.00343	CcSEcCtD
Clomipramine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000776	0.00343	CcSEcCtD
Clomipramine—Flatulence—Liotrix—hypothyroidism	0.000773	0.00341	CcSEcCtD
Clomipramine—Tension—Liotrix—hypothyroidism	0.00077	0.0034	CcSEcCtD
Clomipramine—ADRA2A—gonad—hypothyroidism	0.000769	0.00775	CbGeAlD
Clomipramine—Dysgeusia—Liotrix—hypothyroidism	0.000769	0.00339	CcSEcCtD
Clomipramine—HTR2A—heart—hypothyroidism	0.000764	0.0077	CbGeAlD
Clomipramine—Nervousness—Liotrix—hypothyroidism	0.000762	0.00337	CcSEcCtD
Clomipramine—Fatigue—Levothyroxine—hypothyroidism	0.000751	0.00331	CcSEcCtD
Clomipramine—Fatigue—Dextrothyroxine—hypothyroidism	0.000751	0.00331	CcSEcCtD
Clomipramine—ADRA2A—pituitary gland—hypothyroidism	0.000751	0.00756	CbGeAlD
Clomipramine—Vision blurred—Liotrix—hypothyroidism	0.00074	0.00327	CcSEcCtD
Clomipramine—Tremor—Liotrix—hypothyroidism	0.000735	0.00325	CcSEcCtD
Clomipramine—CYP1A2—blood—hypothyroidism	0.000729	0.00735	CbGeAlD
Clomipramine—Agitation—Liotrix—hypothyroidism	0.000721	0.00318	CcSEcCtD
Clomipramine—HTR2A—cardiovascular system—hypothyroidism	0.000721	0.00726	CbGeAlD
Clomipramine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000718	0.00317	CcSEcCtD
Clomipramine—Feeling abnormal—Levothyroxine—hypothyroidism	0.000718	0.00317	CcSEcCtD
Clomipramine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000712	0.00314	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000712	0.00314	CcSEcCtD
Clomipramine—Syncope—Liotrix—hypothyroidism	0.000704	0.00311	CcSEcCtD
Clomipramine—CYP1A2—thyroid gland—hypothyroidism	0.000704	0.00709	CbGeAlD
Clomipramine—CYP2C19—liver—hypothyroidism	0.000698	0.00703	CbGeAlD
Clomipramine—Palpitations—Liotrix—hypothyroidism	0.000694	0.00306	CcSEcCtD
Clomipramine—Urticaria—Levothyroxine—hypothyroidism	0.000692	0.00305	CcSEcCtD
Clomipramine—Urticaria—Dextrothyroxine—hypothyroidism	0.000692	0.00305	CcSEcCtD
Clomipramine—Loss of consciousness—Liotrix—hypothyroidism	0.00069	0.00305	CcSEcCtD
Clomipramine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000688	0.00304	CcSEcCtD
Clomipramine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000688	0.00304	CcSEcCtD
Clomipramine—Abdominal pain—Levothyroxine—hypothyroidism	0.000688	0.00304	CcSEcCtD
Clomipramine—Body temperature increased—Levothyroxine—hypothyroidism	0.000688	0.00304	CcSEcCtD
Clomipramine—Convulsion—Liotrix—hypothyroidism	0.00068	0.003	CcSEcCtD
Clomipramine—Hypertension—Liotrix—hypothyroidism	0.000678	0.00299	CcSEcCtD
Clomipramine—ADRA2A—adrenal gland—hypothyroidism	0.000671	0.00676	CbGeAlD
Clomipramine—ADRA2A—blood—hypothyroidism	0.00067	0.00676	CbGeAlD
Clomipramine—Arthralgia—Liotrix—hypothyroidism	0.000668	0.00295	CcSEcCtD
Clomipramine—Chest pain—Liotrix—hypothyroidism	0.000668	0.00295	CcSEcCtD
Clomipramine—Anxiety—Liotrix—hypothyroidism	0.000666	0.00294	CcSEcCtD
Clomipramine—HTR2A—gonad—hypothyroidism	0.000654	0.00659	CbGeAlD
Clomipramine—ADRA2A—thyroid gland—hypothyroidism	0.000647	0.00652	CbGeAlD
Clomipramine—Confusional state—Liotrix—hypothyroidism	0.000646	0.00285	CcSEcCtD
Clomipramine—Oedema—Liotrix—hypothyroidism	0.00064	0.00283	CcSEcCtD
Clomipramine—Anaphylactic shock—Liotrix—hypothyroidism	0.00064	0.00283	CcSEcCtD
Clomipramine—HTR2A—pituitary gland—hypothyroidism	0.000638	0.00643	CbGeAlD
Clomipramine—Shock—Liotrix—hypothyroidism	0.00063	0.00278	CcSEcCtD
Clomipramine—ADRA2A—female gonad—hypothyroidism	0.000625	0.0063	CbGeAlD
Clomipramine—Tachycardia—Liotrix—hypothyroidism	0.000625	0.00276	CcSEcCtD
Clomipramine—Asthenia—Levothyroxine—hypothyroidism	0.000625	0.00276	CcSEcCtD
Clomipramine—Asthenia—Dextrothyroxine—hypothyroidism	0.000625	0.00276	CcSEcCtD
Clomipramine—Hyperhidrosis—Liotrix—hypothyroidism	0.000619	0.00273	CcSEcCtD
Clomipramine—Pruritus—Dextrothyroxine—hypothyroidism	0.000616	0.00272	CcSEcCtD
Clomipramine—Pruritus—Levothyroxine—hypothyroidism	0.000616	0.00272	CcSEcCtD
Clomipramine—Anorexia—Liotrix—hypothyroidism	0.000611	0.0027	CcSEcCtD
Clomipramine—Hypotension—Liotrix—hypothyroidism	0.000598	0.00264	CcSEcCtD
Clomipramine—Diarrhoea—Levothyroxine—hypothyroidism	0.000596	0.00263	CcSEcCtD
Clomipramine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000596	0.00263	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000584	0.00258	CcSEcCtD
Clomipramine—Insomnia—Liotrix—hypothyroidism	0.000579	0.00256	CcSEcCtD
Clomipramine—Paraesthesia—Liotrix—hypothyroidism	0.000575	0.00254	CcSEcCtD
Clomipramine—Dyspnoea—Liotrix—hypothyroidism	0.000571	0.00252	CcSEcCtD
Clomipramine—HTR2A—adrenal gland—hypothyroidism	0.00057	0.00575	CbGeAlD
Clomipramine—CYP1A2—liver—hypothyroidism	0.00057	0.00575	CbGeAlD
Clomipramine—HTR2A—blood—hypothyroidism	0.00057	0.00574	CbGeAlD
Clomipramine—Decreased appetite—Liotrix—hypothyroidism	0.000557	0.00246	CcSEcCtD
Clomipramine—ADRA2A—testis—hypothyroidism	0.000555	0.00559	CbGeAlD
Clomipramine—Vomiting—Levothyroxine—hypothyroidism	0.000554	0.00244	CcSEcCtD
Clomipramine—Vomiting—Dextrothyroxine—hypothyroidism	0.000554	0.00244	CcSEcCtD
Clomipramine—Fatigue—Liotrix—hypothyroidism	0.000552	0.00244	CcSEcCtD
Clomipramine—Rash—Dextrothyroxine—hypothyroidism	0.000549	0.00242	CcSEcCtD
Clomipramine—Rash—Levothyroxine—hypothyroidism	0.000549	0.00242	CcSEcCtD
Clomipramine—Dermatitis—Levothyroxine—hypothyroidism	0.000549	0.00242	CcSEcCtD
Clomipramine—Dermatitis—Dextrothyroxine—hypothyroidism	0.000549	0.00242	CcSEcCtD
Clomipramine—Constipation—Liotrix—hypothyroidism	0.000548	0.00242	CcSEcCtD
Clomipramine—Headache—Levothyroxine—hypothyroidism	0.000545	0.00241	CcSEcCtD
Clomipramine—Headache—Dextrothyroxine—hypothyroidism	0.000545	0.00241	CcSEcCtD
Clomipramine—Feeling abnormal—Liotrix—hypothyroidism	0.000528	0.00233	CcSEcCtD
Clomipramine—CYP3A4—blood—hypothyroidism	0.000528	0.00532	CbGeAlD
Clomipramine—Gastrointestinal pain—Liotrix—hypothyroidism	0.000524	0.00231	CcSEcCtD
Clomipramine—CYP2D6—blood—hypothyroidism	0.000519	0.00523	CbGeAlD
Clomipramine—ABCB1—adrenal cortex—hypothyroidism	0.000518	0.00522	CbGeAlD
Clomipramine—Nausea—Dextrothyroxine—hypothyroidism	0.000517	0.00228	CcSEcCtD
Clomipramine—Nausea—Levothyroxine—hypothyroidism	0.000517	0.00228	CcSEcCtD
Clomipramine—ADRA2A—cerebellum—hypothyroidism	0.000512	0.00516	CbGeAlD
Clomipramine—Urticaria—Liotrix—hypothyroidism	0.000509	0.00225	CcSEcCtD
Clomipramine—Abdominal pain—Liotrix—hypothyroidism	0.000506	0.00224	CcSEcCtD
Clomipramine—Body temperature increased—Liotrix—hypothyroidism	0.000506	0.00224	CcSEcCtD
Clomipramine—ABCB1—heart—hypothyroidism	0.000501	0.00504	CbGeAlD
Clomipramine—CYP2D6—female gonad—hypothyroidism	0.000484	0.00488	CbGeAlD
Clomipramine—ABCB1—cardiovascular system—hypothyroidism	0.000472	0.00476	CbGeAlD
Clomipramine—Hypersensitivity—Liotrix—hypothyroidism	0.000472	0.00208	CcSEcCtD
Clomipramine—HTR2A—testis—hypothyroidism	0.000472	0.00475	CbGeAlD
Clomipramine—Asthenia—Liotrix—hypothyroidism	0.00046	0.00203	CcSEcCtD
Clomipramine—Pruritus—Liotrix—hypothyroidism	0.000453	0.002	CcSEcCtD
Clomipramine—HTR2A—liver—hypothyroidism	0.000446	0.00449	CbGeAlD
Clomipramine—Diarrhoea—Liotrix—hypothyroidism	0.000438	0.00194	CcSEcCtD
Clomipramine—HTR2A—cerebellum—hypothyroidism	0.000435	0.00439	CbGeAlD
Clomipramine—CYP2D6—testis—hypothyroidism	0.00043	0.00433	CbGeAlD
Clomipramine—ABCB1—gonad—hypothyroidism	0.000429	0.00432	CbGeAlD
Clomipramine—Dizziness—Liotrix—hypothyroidism	0.000424	0.00187	CcSEcCtD
Clomipramine—ABCB1—pituitary gland—hypothyroidism	0.000418	0.00421	CbGeAlD
Clomipramine—CYP3A4—liver—hypothyroidism	0.000413	0.00416	CbGeAlD
Clomipramine—Vomiting—Liotrix—hypothyroidism	0.000407	0.0018	CcSEcCtD
Clomipramine—CYP2D6—liver—hypothyroidism	0.000406	0.00409	CbGeAlD
Clomipramine—Rash—Liotrix—hypothyroidism	0.000404	0.00178	CcSEcCtD
Clomipramine—Dermatitis—Liotrix—hypothyroidism	0.000403	0.00178	CcSEcCtD
Clomipramine—Headache—Liotrix—hypothyroidism	0.000401	0.00177	CcSEcCtD
Clomipramine—CYP2D6—cerebellum—hypothyroidism	0.000397	0.004	CbGeAlD
Clomipramine—Nausea—Liotrix—hypothyroidism	0.00038	0.00168	CcSEcCtD
Clomipramine—ABCB1—adrenal gland—hypothyroidism	0.000374	0.00377	CbGeAlD
Clomipramine—ABCB1—blood—hypothyroidism	0.000374	0.00376	CbGeAlD
Clomipramine—ABCB1—thyroid gland—hypothyroidism	0.000361	0.00363	CbGeAlD
Clomipramine—ABCB1—female gonad—hypothyroidism	0.000348	0.00351	CbGeAlD
Clomipramine—ABCB1—testis—hypothyroidism	0.000309	0.00311	CbGeAlD
Clomipramine—ABCB1—liver—hypothyroidism	0.000292	0.00294	CbGeAlD
Clomipramine—ABCB1—cerebellum—hypothyroidism	0.000285	0.00288	CbGeAlD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.83e-05	0.00249	CbGpPWpGaD
Clomipramine—ALB—Platelet degranulation—IGF1—hypothyroidism	7.5e-05	0.00239	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.43e-05	0.00236	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TSHR—hypothyroidism	7.41e-05	0.00236	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TSHB—hypothyroidism	7.41e-05	0.00236	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	7.41e-05	0.00236	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.37e-05	0.00235	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TRH—hypothyroidism	7.23e-05	0.0023	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	7.14e-05	0.00227	CbGpPWpGaD
Clomipramine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	7.14e-05	0.00227	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—TSHB—hypothyroidism	7.08e-05	0.00225	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—TSHR—hypothyroidism	7.08e-05	0.00225	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—TRH—hypothyroidism	7.02e-05	0.00224	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—TSHB—hypothyroidism	7.02e-05	0.00223	CbGpPWpGaD
Clomipramine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.86e-05	0.00218	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	6.84e-05	0.00218	CbGpPWpGaD
Clomipramine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.57e-05	0.00209	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—AVP—hypothyroidism	6.53e-05	0.00208	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	6.46e-05	0.00206	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TSHB—hypothyroidism	6.45e-05	0.00205	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	6.45e-05	0.00205	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TRH—hypothyroidism	6.41e-05	0.00204	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TRH—hypothyroidism	6.38e-05	0.00203	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	6.31e-05	0.00201	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—IYD—hypothyroidism	6.31e-05	0.00201	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—TSHB—hypothyroidism	6.26e-05	0.00199	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—TSHR—hypothyroidism	6.26e-05	0.00199	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—PIK3C2A—hypothyroidism	6.25e-05	0.00199	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.11e-05	0.00194	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—AVP—hypothyroidism	5.96e-05	0.0019	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.87e-05	0.00187	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TRH—hypothyroidism	5.82e-05	0.00185	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	5.8e-05	0.00185	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TSHB—hypothyroidism	5.72e-05	0.00182	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TSHR—hypothyroidism	5.72e-05	0.00182	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.7e-05	0.00181	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TSHB—hypothyroidism	5.69e-05	0.00181	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TSHR—hypothyroidism	5.69e-05	0.00181	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CLTC—hypothyroidism	5.68e-05	0.00181	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—POMC—hypothyroidism	5.66e-05	0.0018	CbGpPWpGaD
Clomipramine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.56e-05	0.00177	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.48e-05	0.00174	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	5.4e-05	0.00172	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ATP5O—hypothyroidism	5.37e-05	0.00171	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.35e-05	0.0017	CbGpPWpGaD
Clomipramine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.29e-05	0.00168	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—SLC5A5—hypothyroidism	5.25e-05	0.00167	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.2e-05	0.00166	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	5.19e-05	0.00165	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	5.19e-05	0.00165	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	5.17e-05	0.00165	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SH2B3—hypothyroidism	5.14e-05	0.00163	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TPO—hypothyroidism	5.05e-05	0.00161	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—VAV3—hypothyroidism	4.99e-05	0.00159	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	4.99e-05	0.00159	CbGpPWpGaD
Clomipramine—ALB—Metabolism—IYD—hypothyroidism	4.98e-05	0.00159	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TRH—hypothyroidism	4.91e-05	0.00156	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AVP—hypothyroidism	4.81e-05	0.00153	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—AVP—hypothyroidism	4.81e-05	0.00153	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TRH—hypothyroidism	4.7e-05	0.00149	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.62e-05	0.00147	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	4.61e-05	0.00147	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	4.61e-05	0.00147	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	4.57e-05	0.00145	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—VAV3—hypothyroidism	4.53e-05	0.00144	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TRH—hypothyroidism	4.49e-05	0.00143	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—IYD—hypothyroidism	4.47e-05	0.00142	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TSHB—hypothyroidism	4.38e-05	0.00139	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TSHR—hypothyroidism	4.38e-05	0.00139	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AVP—hypothyroidism	4.37e-05	0.00139	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—IYD—hypothyroidism	4.37e-05	0.00139	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CLTC—hypothyroidism	4.36e-05	0.00139	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—POMC—hypothyroidism	4.34e-05	0.00138	CbGpPWpGaD
Clomipramine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.29e-05	0.00137	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ATP5O—hypothyroidism	4.24e-05	0.00135	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	4.21e-05	0.00134	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.2e-05	0.00134	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	4.19e-05	0.00133	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	4.19e-05	0.00133	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—AVP—hypothyroidism	4.18e-05	0.00133	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	4.17e-05	0.00133	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—IYD—hypothyroidism	4.11e-05	0.00131	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	4.09e-05	0.0013	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TRH—hypothyroidism	4.08e-05	0.0013	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SH2B3—hypothyroidism	4.05e-05	0.00129	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TSHB—hypothyroidism	4e-05	0.00127	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TSHR—hypothyroidism	4e-05	0.00127	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TPO—hypothyroidism	3.98e-05	0.00127	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CLTC—hypothyroidism	3.98e-05	0.00127	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—POMC—hypothyroidism	3.96e-05	0.00126	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SH2B3—hypothyroidism	3.9e-05	0.00124	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	3.83e-05	0.00122	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ATP5O—hypothyroidism	3.8e-05	0.00121	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	3.8e-05	0.00121	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—POMC—hypothyroidism	3.79e-05	0.00121	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TRH—hypothyroidism	3.77e-05	0.0012	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ATP5O—hypothyroidism	3.71e-05	0.00118	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	3.71e-05	0.00118	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.69e-05	0.00117	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AVP—hypothyroidism	3.69e-05	0.00117	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.64e-05	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	3.64e-05	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	3.64e-05	0.00116	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TSHB—hypothyroidism	3.64e-05	0.00116	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TSHR—hypothyroidism	3.64e-05	0.00116	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TPO—hypothyroidism	3.58e-05	0.00114	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VAV3—hypothyroidism	3.53e-05	0.00112	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ATP5O—hypothyroidism	3.5e-05	0.00111	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	3.5e-05	0.00111	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TPO—hypothyroidism	3.49e-05	0.00111	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—POMC—hypothyroidism	3.49e-05	0.00111	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—IYD—hypothyroidism	3.49e-05	0.00111	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—VAV3—hypothyroidism	3.48e-05	0.00111	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TRH—hypothyroidism	3.44e-05	0.00109	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	3.37e-05	0.00107	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TSHR—hypothyroidism	3.36e-05	0.00107	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TSHB—hypothyroidism	3.36e-05	0.00107	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AVP—hypothyroidism	3.35e-05	0.00107	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.32e-05	0.00106	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.32e-05	0.00105	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.31e-05	0.00105	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	3.31e-05	0.00105	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	3.31e-05	0.00105	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TPO—hypothyroidism	3.29e-05	0.00105	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.27e-05	0.00104	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CLTC—hypothyroidism	3.21e-05	0.00102	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—POMC—hypothyroidism	3.2e-05	0.00102	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—POMC—hypothyroidism	3.2e-05	0.00102	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	3.17e-05	0.00101	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TSHB—hypothyroidism	3.07e-05	0.000976	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TSHR—hypothyroidism	3.07e-05	0.000976	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AVP—hypothyroidism	3.06e-05	0.000973	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SH2B3—hypothyroidism	2.99e-05	0.000953	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ATP5O—hypothyroidism	2.96e-05	0.000943	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—POMC—hypothyroidism	2.95e-05	0.00094	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.95e-05	0.000938	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—POMC—hypothyroidism	2.9e-05	0.000924	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PRL—hypothyroidism	2.9e-05	0.000921	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	2.82e-05	0.000898	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CLTC—hypothyroidism	2.79e-05	0.000887	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TPO—hypothyroidism	2.79e-05	0.000887	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VAV3—hypothyroidism	2.78e-05	0.000885	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TRH—hypothyroidism	2.78e-05	0.000883	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—POMC—hypothyroidism	2.77e-05	0.000883	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—POMC—hypothyroidism	2.75e-05	0.000874	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	2.73e-05	0.00087	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	2.72e-05	0.000865	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—IYD—hypothyroidism	2.69e-05	0.000856	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VAV3—hypothyroidism	2.68e-05	0.000852	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.58e-05	0.000822	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.58e-05	0.000822	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AVP—hypothyroidism	2.58e-05	0.000821	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	2.56e-05	0.000815	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	2.54e-05	0.000807	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	2.52e-05	0.000803	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSHB—hypothyroidism	2.47e-05	0.000787	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TSHR—hypothyroidism	2.47e-05	0.000787	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AVP—hypothyroidism	2.47e-05	0.000785	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—POMC—hypothyroidism	2.45e-05	0.00078	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	2.45e-05	0.000779	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TRH—hypothyroidism	2.41e-05	0.000767	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	2.36e-05	0.000751	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TSHB—hypothyroidism	2.34e-05	0.000744	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.32e-05	0.000738	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.29e-05	0.000728	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.28e-05	0.000726	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	2.24e-05	0.000712	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	2.23e-05	0.000709	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—POMC—hypothyroidism	2.23e-05	0.000709	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	2.22e-05	0.000708	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PRL—hypothyroidism	2.22e-05	0.000707	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	2.2e-05	0.000701	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	2.19e-05	0.000698	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IGF1—hypothyroidism	2.17e-05	0.000691	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TPO—hypothyroidism	2.15e-05	0.000684	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSHB—hypothyroidism	2.15e-05	0.000683	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TSHR—hypothyroidism	2.15e-05	0.000683	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	2.15e-05	0.000683	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AVP—hypothyroidism	2.14e-05	0.000682	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	2.08e-05	0.000663	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VAV3—hypothyroidism	2.05e-05	0.000654	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.03e-05	0.000647	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—POMC—hypothyroidism	2.03e-05	0.000647	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PRL—hypothyroidism	2.03e-05	0.000645	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	2.02e-05	0.000644	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AVP—hypothyroidism	1.98e-05	0.00063	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	1.95e-05	0.000622	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	1.95e-05	0.000622	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	1.95e-05	0.00062	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	1.91e-05	0.000609	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VAV3—hypothyroidism	1.88e-05	0.000597	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TSHB—hypothyroidism	1.84e-05	0.000587	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AVP—hypothyroidism	1.81e-05	0.000575	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	1.81e-05	0.000575	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	1.75e-05	0.000557	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	1.74e-05	0.000554	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—POMC—hypothyroidism	1.72e-05	0.000546	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IGF1—hypothyroidism	1.71e-05	0.000545	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TSHB—hypothyroidism	1.66e-05	0.000527	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IGF1—hypothyroidism	1.65e-05	0.000525	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PIK3C2A—hypothyroidism	1.64e-05	0.000523	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—POMC—hypothyroidism	1.64e-05	0.000522	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PRL—hypothyroidism	1.64e-05	0.00052	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.62e-05	0.000516	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TSHB—hypothyroidism	1.62e-05	0.000514	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	1.57e-05	0.000499	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TSHB—hypothyroidism	1.52e-05	0.000485	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VAV3—hypothyroidism	1.51e-05	0.000481	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.48e-05	0.00047	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AVP—hypothyroidism	1.46e-05	0.000464	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.46e-05	0.000463	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.44e-05	0.000458	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	1.43e-05	0.000454	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—POMC—hypothyroidism	1.42e-05	0.000453	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PRL—hypothyroidism	1.42e-05	0.000452	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC5A5—hypothyroidism	1.38e-05	0.000439	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.36e-05	0.000432	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—hypothyroidism	1.32e-05	0.000419	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VAV3—hypothyroidism	1.31e-05	0.000418	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	1.3e-05	0.000412	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	1.29e-05	0.000411	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TSHB—hypothyroidism	1.29e-05	0.00041	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AVP—hypothyroidism	1.27e-05	0.000403	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1—hypothyroidism	1.27e-05	0.000403	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1.24e-05	0.000394	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.21e-05	0.000385	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—hypothyroidism	1.2e-05	0.000382	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	1.2e-05	0.00038	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1—hypothyroidism	1.16e-05	0.000368	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	1.15e-05	0.000366	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.15e-05	0.000366	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC5A5—hypothyroidism	1.14e-05	0.000363	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.13e-05	0.000361	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TSHB—hypothyroidism	9.96e-06	0.000317	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—hypothyroidism	9.69e-06	0.000308	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	9.66e-06	0.000307	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1—hypothyroidism	9.32e-06	0.000297	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—hypothyroidism	9.15e-06	0.000291	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.87e-06	0.000282	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—hypothyroidism	8.41e-06	0.000268	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1—hypothyroidism	8.09e-06	0.000257	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	7.65e-06	0.000244	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.45e-06	0.000237	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	7.36e-06	0.000234	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—hypothyroidism	7.22e-06	0.00023	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—hypothyroidism	6.48e-06	0.000206	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—hypothyroidism	6.33e-06	0.000201	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—hypothyroidism	5.96e-06	0.00019	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—hypothyroidism	5.05e-06	0.000161	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—hypothyroidism	3.9e-06	0.000124	CbGpPWpGaD
